← Back to all trials
Completed
NCT07765459
the Effect of Interdialytic Serum Bicarbonate Correction on Vascular Calcification in Hemodialysis Patients
Conditions: End Stage Renal Disease (ESRD), Metabolic Acidosis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE1
Enrollment: 40
Sponsor: Ain Shams University
Location: Ainshams university Cairo Egypt
Summary
the investigators will test the effect of interdialytic metabolic acidosis correction on vascular calcification in hemodialysis patients
Eligibility Criteria
Inclusion Criteria:
Adult prevalent hemodialysis patients (age 18 years or older) On regular hemodialysis for more than 6 months, with three sessions per week, each lasting four hours Metabolic acidosis at the time of recruitment, defined as a serum bicarbonate level ≤22 mmol/L for at least 6 months before the study
Exclusion Criteria:
Patients with hemodialysis catheters Active inflammation, infection, or active malignancy History of parathyroidectomy Other organ failure, such as decompensated heart failure or liver failure
Source: ClinicalTrials.gov (NCT07765459). StuddyBuddy aggregates publicly available trial information.
